Breast cancer resistance protein (BCRP) was first identified in a drug-resistant human breast cancer cell line that was treated simultaneously with mitoxantrone and Tariquidar, which are P-gp inhibitors [34,42,43]. Here, ABCG2 is linked to breast carcinoma.